Compare MUA & SIBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MUA | SIBN |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.0M | 778.8M |
| IPO Year | 1994 | 2018 |
| Metric | MUA | SIBN |
|---|---|---|
| Price | $9.30 | $19.30 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $25.22 |
| AVG Volume (30 Days) | 489.8K | ★ 539.0K |
| Earning Date | 01-01-0001 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 41.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,301,000.00 |
| Revenue This Year | N/A | $15.53 |
| Revenue Next Year | N/A | $15.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 21.53 |
| 52 Week Low | $9.13 | $11.48 |
| 52 Week High | $11.26 | $21.89 |
| Indicator | MUA | SIBN |
|---|---|---|
| Relative Strength Index (RSI) | 34.78 | 55.12 |
| Support Level | $9.26 | $17.95 |
| Resistance Level | $9.76 | $19.35 |
| Average True Range (ATR) | 0.14 | 0.65 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 29.70 | 64.39 |
Blackrock Muniassets Fund Inc is a closed-end fund. Its objective is to provide high current income exempt from U.S. federal income taxes by investing in a portfolio of medium- to lower-grade or unrated municipal obligations. The Fund invests more of its total assets in municipal bonds.
SI-BONE Inc is a medical device company that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ, and iFuse Bedrock Granite, which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.